Pharma & Life Sciences
Understand where disease burden - and need - is heading.
For organizations developing vaccines, therapeutics, diagnostics and vector control products, Epinova is designed to provide geographic disease intelligence that informs development, access and public health partnership strategy.
Epinova modules for Pharma & Life Sciences
- Epinova Signal
- Epinova Predict
- Epinova Prioritize
Built for life sciences
See where burden is moving
Sub-national risk trends for malaria and dengue, linked to climate and population data, to inform countermeasure planning, trial-site context and public health partnerships.
- 01Sub-national burden trends, not just national totals
- 02Climate-linked view of where risk is shifting
- 03Transparent methods for partnership credibility
Your challenges
What makes this work hard today
Shifting burden
Climate and urbanization are changing where vector-borne diseases occur.
Coarse data
National statistics mask sub-national variation relevant to access and trials.
Supply planning
Countermeasure demand is hard to anticipate geographically.
Partnership credibility
Public health partnerships require independent, transparent evidence.
Typical use cases
Where it could make a difference
Geographic opportunity analysis
Where unmet need is greatest and growing.
Medical countermeasure planning
Anticipate regional demand for diagnostics, vaccines and vector control.
Clinical study context
Transmission seasonality and geographic risk for study planning.
Public health partnerships
Shared evidence base with governments and NGOs.
Expected workflow improvements
From today’s workflow to a connected one
These describe intended design outcomes, not measured results.
Implementation approach
A careful path from pilot to scale
- 01
Scoping
Define diseases, geographies and decisions to support.
- 02
Analysis
Bespoke intelligence briefings during platform development.
- 03
Subscription
Ongoing access to intelligence products (planned).